Industry Portals
Biotechnical Industry News
Integer a velit nec risus malesuada imperdiet id et odio. Nunc sit amet mauris dapibus, feugiat diam eget, suscipit, nam gravida nulla eget turpis commodo.
Young & Partners 2021 Pharmaceutical Executive Summit: Doug Long: The Pharmaceutical Market: Trends, Issues and Outlook
Doug Long, Vice President, IQVIA Holdings Inc.
Young & Partners 2021 Pharmaceutical Executive Summit: Stephen Cutler: Innovation in Clinical Development
Dr. Stephen Cutler, CEO, ICON plc
Young & Partners 2021 Pharmaceutical Executive Summit: Christopher Austin Keynote Speech & Fireside Chat: How Cutting Edge Science is Driving the Development of New Medical Products
Dr. Christopher Austin, CEO-Partner, Flagship Pioneering
Société de Chimie Industrielle Webcast: The Evolving Impact of ESG on the Chemical Industry
Joseph Chang, Global Editor, ICIS Chemical Business; Robert Westervelt, Editor in Chief, IHS Markit Chemical Week
Pharm Exec: Doubling Down On Innovation, Recovery (Young & Partners article – September 2021)
While activity and outputs have been mixed, and pandemic challenges linger on, the outlooks for pharma and biotech remain stable
Mixed outlook for chemical financing (ICIS Chemical Business August 27, 2021)
Young & Partners documents slower, but still healthy debt and equity issuance
Chemical M&A market in transition (ICIS Chemical Business August 20, 2021)
Slow M&A market begins to pick up, but with many underlying changes
Young & Partners Forum: “Disruptions to the Industry Structure and How to Adjust”
Peter Young of Young & Partners and Dewey Johnson of IHS Markit discuss how structural changes in the industry happen and what companies need to do to adjust their strategies.
Pharm Exec: Pharma and Biotech’s 2020 Full-Year View (Young & Partners article – March 2021)
Examines the key biopharma stock numbers and industry trends from a year that challenged like never before